Hepcludex Injection, Powder, Lyophilized, For Solution
Product Images NDC 61958-3104

Product Visual Gallery

This gallery contains 55 technical images submitted to the FDA as part of the official labeling for Hepcludex (NDC 61958-3104). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gilead Sciences, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Hepcludex 01)

Chemical structure of bulevirtide, the active ingredient in HEPCLUDEX injection, powder, lyophilized, for solution, used subcutaneously and labeled by Gilead Sciences, Inc.*

FDA Label Image

Hepcludex-2 (Hepcludex 02)

An illustration of a HEPCLUDEX vial showing components labeled, including a green vial cap, gray rubber stopper beneath the cap, and a label area indicating the expiration date. The vial contains white to off-white powder or cake for reconstitution.*

FDA Label Image

Hepcludex-3 (Hepcludex 03)

An illustration of a vial containing sterile water, labeled with components including the vial cap and rubber stopper (located under the cap). The vial appears designed for injection use, showing the liquid level and vial structure.*

FDA Label Image

Hepcludex-4 (Hepcludex 04)

An instructional diagram showing a syringe needle with labeled parts: needle cap, needle, and needle tip. The illustration highlights the key components of the needle for a subcutaneous injection device.*

FDA Label Image

Hepcludex-5 (Hepcludex 05)

An illustration of a sterile syringe labeled with its parts: plunger, body, and syringe tip. The diagram visually identifies these primary components of the syringe without additional product branding or dosage information.*

FDA Label Image

Hepcludex-6 (Hepcludex 06)

An instructional diagram of a medical needle showing labeled parts including the needle safety shield, needle, and needle cap. The needle is positioned horizontally with the safety shield covering part of it.*

FDA Label Image

Hepcludex-7 (Hepcludex 07)

Illustration showing supplies for injection administration including a sharps disposal container, adhesive bandage, cotton ball or gauze, and alcohol swabs. Each item is labeled and depicted to facilitate proper handling and post-injection care.*

FDA Label Image

Hepcludex-8 (Hepcludex 08)

Illustration depicting a HEPCLUDEX vial featuring a green cap and a label area highlighting the expiration date formatted as YYYY/MM. The vial is labeled as HEPCLUDEX Vial, corresponding to the human prescription drug Bulevirtide in lyophilized powder form for subcutaneous injection.*

FDA Label Image

Hepcludex-9 (Hepcludex 09)

Illustration showing a pair of hands being washed under running water with soap, depicting proper handwashing technique as part of hygiene or preparation.*

FDA Label Image

Hepcludex-10 (Hepcludex 10)

An instructional illustration showing a hand holding a vial labeled HEPCLUDEX. The vial contains lyophilized powder or cake that should be checked before use. The image highlights the vial's label and the powder inside, indicating inspection prior to administration.*

FDA Label Image

Hepcludex-11 (Hepcludex 11)

An instructional illustration showing the removal of the green cap from a HEPCLUDEX vial intended for subcutaneous injection. The vial is labeled with the brand name HEPCLUDEX, depicting a step in drug preparation or administration.*

FDA Label Image

Hepcludex-12 (Hepcludex 12)

An instructional illustration showing hands removing the cap from a vial labeled 'Sterile Water for Injection.' The image appears to be part of a series demonstrating preparation steps, likely for reconstituting a lyophilized powder injection.*

FDA Label Image

Hepcludex-13 (Hepcludex 13)

An instructional illustration showing how to hold and prepare a HEPCLUDEX vial. The vial is labeled with the product name and is held by one hand at the base while the other hand removes or secures the cap. This image supports safe handling of the HEPCLUDEX injection, powder, lyophilized, for solution.*

FDA Label Image

Hepcludex-14 (Hepcludex 14)

An instructional illustration showing a hand peeling back the cap of a vial labeled 'Sterile Water for Injection Vial,' likely demonstrating preparation for mixing or administering an injection.*

FDA Label Image

Hepcludex-15 (Hepcludex 15)

An instructional illustration showing hands preparing a syringe by twisting and removing the cap from the needle prior to injection. The image demonstrates a step in the preparation of a subcutaneous injection, consistent with reconstitution and administration of a lyophilized powder product.*

FDA Label Image

Hepcludex-16 (Hepcludex 16)

Illustration showing a hand holding a syringe and another hand removing the protective cap from the needle, demonstrating preparation of an injection, likely related to the subcutaneous administration of HEPCLUDEX (bulevirtide) injection powder for solution.*

FDA Label Image

Hepcludex-17 (Hepcludex 17)

An instructional illustration showing hands inserting a syringe needle into a vial labeled 'Sterile Water for Injection.' The vial appears to be used for reconstituting a lyophilized powder injection.*

FDA Label Image

Hepcludex-18 (Hepcludex 18)

Instructional illustration showing a hand holding a syringe drawing fluid from a vial labeled "Sterile Water for Injection." The image includes a close-up of the syringe barrel with volume markings, highlighting the 1 mL mark. Text instructs to align the top rim of the syringe plunger with the 1 mL marking for accurate measurement.*

FDA Label Image

Hepcludex-19 (Hepcludex 19)

Illustration showing a hand holding a vial labeled 'Sterile Water for Injection' and another hand inserting a syringe needle into the vial's rubber stopper, with a blue arrow indicating the direction of needle insertion.*

FDA Label Image

Hepcludex-20 (Hepcludex 20)

An instructional illustration showing a hand holding a syringe with a needle attached, drawing 2 mL of liquid from a vial or container. The image includes a marked 2 mL measurement and a downward arrow indicating the direction or action related to the syringe.*

FDA Label Image

Hepcludex-21 (Hepcludex 21)

An instructional illustration showing hands holding a HEPCLUDEX vial and a syringe. The syringe needle is positioned above the vial's rubber stopper with a downward arrow indicating insertion for withdrawal of the medication. The vial is labeled HEPCLUDEX.*

FDA Label Image

Hepcludex-22 (Hepcludex 22)

An instructional illustration shows a hand holding a syringe drawing solution from a vial by pulling back the plunger. The vial is inverted above the syringe, indicating the preparation of an injection dose.*

FDA Label Image

Hepcludex-23 (Hepcludex 23)

An instructional illustration depicting the preparation of a subcutaneous injection. The image shows a hand holding a vial labeled 'Bulevirtide' with the other hand drawing the solution into a syringe from the vial, indicated by an upward arrow guiding the needle insertion.*

FDA Label Image

Hepcludex-24 (Hepcludex 24)

An instructional illustration depicting how to handle an injection needle during preparation. It shows hands holding a syringe with a needle cap and emphasizing to only touch the cap when the needle is covered, with arrows indicating movement.*

FDA Label Image

Hepcludex-25 (Hepcludex 25)

An instructional illustration showing a hand holding a vial of HEPCLUDEX (bulevirtide) lyophilized powder for injection. The text advises not to shake the vial but to swirl it slowly, demonstrated by a circular arrow near the fingers.*

FDA Label Image

Hepcludex-26 (Hepcludex 26)

Illustration showing a vial of HEPCLUDEX (Bulevirtide) injection, powder, lyophilized, for solution with an associated timer indicating 3 minutes, possibly representing a waiting or preparation time after reconstitution. The vial has a label placeholder and a cap.*

FDA Label Image

Hepcludex-27 (Hepcludex 27)

An instructional illustration showing a hand holding a small vial of injection powder with a focus on the expiration date label. The vial contains a lyophilized powder for solution, highlighting the importance of checking the expiration date before use.*

FDA Label Image

Hepcludex-28 (Hepcludex 28)

An instructional illustration showing two hands preparing a syringe by attaching or twisting a needle onto the syringe tip. The image emphasizes the proper connection technique for injection preparation.*

FDA Label Image

Hepcludex-29 (Hepcludex 29)

An instructional illustration showing hands preparing a syringe by fitting a needle onto the syringe tip with a twisting motion. This step is part of medication preparation, likely for subcutaneous injection.*

FDA Label Image

Hepcludex-30 (Hepcludex 30)

An instructional illustration showing a person holding a syringe with one hand and inserting or removing a needle cap with the other hand. The image demonstrates proper technique related to syringe preparation or injection.*

FDA Label Image

Hepcludex-31 (Hepcludex 31)

An instructional illustration shows a hand improperly injecting a syringe needle straight down into the vial labeled 'Mixed HEPCLUDEX,' with a large X in the top left corner indicating this method is incorrect. The vial is held steady by another hand, emphasizing improper technique for drawing the solution from the vial.*

FDA Label Image

Hepcludex-32 (Hepcludex 32)

An instructional illustration showing a hand holding a syringe and pressing the plunger down to withdraw liquid from a vial. The vial is held steady by the other hand below the syringe needle. The image appears to demonstrate the process of drawing medication from a vial into a syringe.*

FDA Label Image

Hepcludex-33 (Hepcludex 33)

An instructional diagram showing the steps to reconstitute HEPCLUDEX injection powder. It depicts a hand holding a syringe with the vial upside down, with an arrow indicating to hold the plunger in while turning the vial upwards for proper preparation before injection.*

FDA Label Image

Hepcludex-34 (Hepcludex 34)

An instructional diagram showing how to pull the needle tip down and check it through a gap in a medical device connection, likely related to preparation or administration steps for an injection product.*

FDA Label Image

Hepcludex-35 (Hepcludex 35)

An instructional illustration showing hands preparing a syringe for injection. One hand holds the syringe barrel while the other pushes the plunger downward. A circular inset zooms in on the syringe tip connection. This demonstrates part of the process for preparing a subcutaneous injection.*

FDA Label Image

Hepcludex-36 (Hepcludex 36)

An instructional illustration showing a hand holding a syringe with the plunger held in place. A close-up inset highlights the syringe's plunger top for clarity. Text below instructs to "Hold the plunger in place." The image is likely part of administration instructions for HEPCLUDEX injection.*

FDA Label Image

Hepcludex-37 (Hepcludex 37)

An instructional illustration showing a hand holding a syringe and removing it from a vial. Text below instructs to hold the syringe body and plunger while removing the syringe. The image demonstrates part of the preparation process for HEPCLUDEX injection.*

FDA Label Image

Hepcludex-38 (Hepcludex 38)

An instructional illustration showing a hand covering the needle of a syringe with its cap. Text on the image advises to only touch the cap when the needle is covered, demonstrating safe handling during injection preparation.*

FDA Label Image

Hepcludex-39 (Hepcludex 39)

Instructional illustration showing a hand holding a syringe and attaching or removing a needle cap with a twisting motion indicated by a blue arrow. The image is related to the preparation or administration of an injectable medication.*

FDA Label Image

Hepcludex-40 (Hepcludex 40)

Illustration showing how to attach a cap or cover to a syringe. A hand holds a small vial or cap, positioned above the syringe with a rotating arrow indicating the direction to twist or place the cap onto the syringe barrel.*

FDA Label Image

Hepcludex-41 (Hepcludex 41)

An instructional illustration showing a hand holding and preparing a syringe. The syringe appears to be connected to a vial or capped device, indicating preparation for injection, consistent with subcutaneous administration technique.*

FDA Label Image

Hepcludex-42 (Hepcludex 42)

An instructional diagram showing the recommended injection sites for self or caregiver administration of a subcutaneous injection. The diagram highlights the lower abdomen and upper thigh areas on a human figure as suitable injection locations.*

FDA Label Image

Hepcludex-43 (Hepcludex 43)

Illustration showing the recommended injection sites for subcutaneous administration of HEPCLUDEX (bulevirtide) on the back of the upper arms. The diagram depicts a back view of a human torso with both upper arms highlighted in orange as injection areas, accompanied by text indicating 'Back of Upper Arm' and 'Caregiver Only.'*

FDA Label Image

Hepcludex-44 (Hepcludex 44)

An instructional illustration showing a hand holding a small adhesive patch being applied to the skin on the forearm. The patch is rectangular and appears to be gently pressed onto the skin surface.*

FDA Label Image

Hepcludex-45 (Hepcludex 45)

An instructional illustration showing hands preparing a syringe by removing a protective cap or seal. The image depicts the proper technique for handling the syringe and packaging, likely as part of the preparation for subcutaneous injection of the medication.*

FDA Label Image

Hepcludex-46 (Hepcludex 46)

An instructional illustration showing the hands preparing a syringe by attaching a needle. The image depicts removing the needle cap with a blue arrow indicating the direction of movement. The syringe and needle are held in opposite hands, emphasizing the preparation step for injection.*

FDA Label Image

Hepcludex-47 (Hepcludex 47)

Illustrations showing proper syringe handling before injection. The first panel instructs to remove large air gaps from the syringe by pushing liquid upward. The second panel shows a syringe with the needle cap off and small bubbles, labeled as normal. The third panel shows a syringe with a large air gap not removed, marked incorrect. This diagram highlights safe air bubble management in injection preparation.*

FDA Label Image

Hepcludex-48 (Hepcludex 48)

An instructional illustration showing a hand pinching the skin on a person's upper arm, demonstrating how to prepare the skin for a subcutaneous injection.*

FDA Label Image

Hepcludex-49 (Hepcludex 49)

Instructional illustration showing the proper subcutaneous injection angle for administering medication using a syringe. The image indicates two angles, 90 degrees and 45 degrees, with a focus on inserting the needle at approximately 45 degrees into the skin.*

FDA Label Image

Hepcludex-50 (Hepcludex 50)

An instructional diagram showing a hand holding and adjusting a cap or cover piece of a small medical device or injector, with an arrow indicating the direction to flip the cap open or closed. This image likely demonstrates part of the preparation or usage process for an injectable drug delivery system.*

FDA Label Image

Hepcludex-51 (Hepcludex 51)

An instructional illustration showing a hand holding and pressing the top of a device or component, with motion lines indicating an action such as releasing or activating a part. The image likely demonstrates a step in preparing or using a product but does not contain text or specific product details.*

FDA Label Image

Hepcludex-52 (Hepcludex 52)

Illustration showing a hand disposing a used syringe into a red sharps container labeled "Sharps." Two capped needles are already inside the container. The container is designed for safe disposal of injection-related materials.*

FDA Label Image

Hepcludex-53 (Hepcludex 53)

Illustration showing a hand holding a cotton ball or pad and pressing it against the skin, suggesting an injection site preparation or post-injection care step.*

FDA Label Image

Label (Hepcludex 54)

HEPCLUDEX 8.5 mg per vial injection, powder for solution, for subcutaneous use. The label shows it contains bulevirtide-gmod as the active ingredient. It is a single-dose vial labeled for prescription use only, manufactured by Gilead Sciences, Inc. The label also notes storage at 25°C (77°F) and states 'Product of China.'*

FDA Label Image

Label (Hepcludex 55)

HEPCLUDEX 8.5 mg per vial injection, lyophilized powder for subcutaneous use, containing the active ingredient bulevirtide-gmod. The label includes the product name, strength, dosage form, route, and instructions to reconstitute prior to use. It is manufactured by Gilead Sciences, Inc. and has a package indicating 30 single-dose vials with disposal instructions for unused portions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.